NL-OMON55157招募中不适用
ATTR amyloidosis in patients undergoing transcatheter aortic valve replacement: from prevalence to hemodynamic consequence. - AMLO-TAVR
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 340
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Severe symptomatic aortic valve stenosis
排除标准
- •- Unable to undergo scintigraphy
研究者
相似试验
招募中
不适用
Transthyretin amyloidosis (ATTR) in TAVR patients - establishment of a multicenter register (TAP-TAVI register)I43.1I35.0Cardiomyopathy in metabolic diseasesAortic (valve) stenosisDRKS00025129niklinik Köln, Kardiologie600
招募中
3 期
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantTransthyretin AmyloidosisAmyloidosisNCT06563895Eidos Therapeutics, a BridgeBio company587
已完成
不适用
ATTR amyloidosis in patients with heart failure with preserved ejection fraction and a cardiac implantable electronic deviceProtein misfolding disease10082206NL-OMON49286niversitair Medisch Centrum Groningen100
尚未招募
不适用
Follow-up of patients with transthyretin amyloid cardiomyopathy by multi-modality imagingE85AmyloidosisDRKS00033884Deutsches Herzzentrum der Charité60
进行中（未招募）
不适用
The purpose of this substudy is to describe the collection of bloodsamples to be used for development and validation of a biomarker assay.EUCTR2013-004090-28-ITFold RX Pharmaceuticals, a Pfizer Company45